Top compounds associated with response to THYN1


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.097 0.005
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.11 0.006
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.006
mRNA manumycin A CTRPv2 pan-cancer AAC 0.095 0.006
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.006
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.006
mRNA TAK-715 GDSC1000 pan-cancer AAC 0.094 0.007
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.1 0.007
mRNA ZM-447439 GDSC1000 pan-cancer AAC 0.1 0.007
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.095 0.007
Download CSV